Using a computerized attention test to help manage concussion in young rugby players
Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players
NA · University Hospital, Clermont-Ferrand · NCT05719844
We will test if a computerized attention battery can detect attention problems after concussion in 11–25-year-old rugby players by comparing them with similar athletes without concussion.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 11 Years to 25 Years |
| Sex | Male |
| Sponsor | University Hospital, Clermont-Ferrand (other) |
| Locations | 1 site (Clermont-Ferrand) |
| Trial ID | NCT05719844 on ClinicalTrials.gov |
What this trial studies
Researchers will recruit 30 young rugby players aged 11–25 who sustained a concussion and a matched control group of non-contact sport athletes. Participants will complete the TAP computerized attention battery plus standard French paper-and-pencil neuropsychological tests of processing speed, short-term and working memory, episodic memory, and selective attention. Scores will be compared between concussed players and matched controls and correlated with concussion symptom profiles. The aim is to see whether the computerized battery is more sensitive and could shorten assessment time to enable earlier rehabilitative interventions.
Who should consider this trial
Good fit: Ideal candidates are 11–25-year-old rugby players who sustained a concussion and read French, along with age- and education-matched non-contact sport athletes without concussion to serve as controls.
Not a fit: Patients with prior neurological or psychiatric disorders, diagnosed neurodevelopmental disorders, significant intellectual impairment, active addictive behaviors, current major depressive disorder or recent treatment with antidepressants/benzodiazepines, or those under legal protection are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, this approach could provide quicker, more specific neuropsychological assessments after concussion, allowing earlier targeted rehabilitation and safer return-to-play decisions.
How similar studies have performed: Other computerized concussion batteries (for example, ImPACT) have shown utility in sports concussion management, but applying the TAP battery specifically in young rugby players is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients : * concussion in the context of the practice of rugby * French or reading French without help * Controls : * no concussion * practicing a non-contact sport (athletics, rowing, badminton, capoeira, circus, running, crossfit, cycling, dancing, climbing, fencing, fitness, golf, gymnastics, bodybuilding, swimming, skating, Qi Gong, Taï chi, tennis, table tennis, shooting, trail running, volleyball, water polo) within a sports association * age matched to patient (+/- 1 year) * study level matched to patient (+/- 1 year) * French or reading French without help Exclusion Criteria: * Patients : * Legal protection measure * Other neurological or psychiatric pathologies prior to concussion episodes * Diagnosis of a neurodevelopmental disorder in childhood * Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation) * Addictive behaviors * Current major depressive disorder or treated with antidepressants or benzodiazepines for less than 3 months * Severe visual or motor problems that may interfere with the performance of the tests * Controls : * Legal protection measure * History of proven concussion * Other neurological or psychiatric pathologies * Diagnosis of a neurodevelopmental disorder in childhood * Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation) * Addictive behaviors * Current major depressive episode or treated with antidepressants or benzodiazepines for less than 3 months * Severe visual or motor problems that may interfere with the performance of the tests
Where this trial is running
Clermont-Ferrand
- CHU de Clermont-Ferrand — Clermont-Ferrand, France (RECRUITING)
Study contacts
- Principal investigator: Tiphaine Vidal — University Hospital, Clermont-Ferrand
- Study coordinator: Lise LACLAUTRE
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +334.73.754.963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Concussion, Brain